59.25
+0.27
+(0.46%)
At close: 4:00:01 PM EST
59.30
+0.05
+(0.08%)
After hours: 5:06:51 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
46,007.00
35,311.00
17,687.00
29,040.00
17,572.00
Investing Cash Flow
-72,471.00
-3,130.00
-36,206.00
-3,501.00
-17,160.00
Financing Cash Flow
13,253.00
3,618.00
1,045.00
9,171.00
6,441.00
End Cash Position
70,350.00
86,866.00
51,067.00
68,541.00
33,831.00
Income Tax Paid Supplemental Data
--
1,166.00
--
379.00
147.00
Interest Paid Supplemental Data
--
383.00
109.00
4.00
6.00
Capital Expenditure
-58,022.00
-27,513.00
-7,596.00
-7,915.00
-2,626.00
Issuance of Capital Stock
18,641.00
6,000.00
3,652.00
11,184.00
6,632.00
Free Cash Flow
-12,015.00
7,798.00
10,091.00
21,125.00
14,946.00
12/31/2020 - 2/4/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDWD MediWound Ltd.
19.88
-0.40%
INBX Inhibrx Biosciences, Inc.
13.55
+10.07%
PRAX Praxis Precision Medicines, Inc.
76.20
+2.95%
DNLI Denali Therapeutics Inc.
23.58
+0.73%
BHVN Biohaven Ltd.
39.00
+3.37%
TGTX TG Therapeutics, Inc.
33.36
-0.03%
JANX Janux Therapeutics, Inc.
44.79
+5.36%
CPRX Catalyst Pharmaceuticals, Inc.
23.19
-3.21%
MESO Mesoblast Limited
19.52
-0.15%
ARQT Arcutis Biotherapeutics, Inc.
13.67
-0.36%